The U.S. Surgeon General says he expects a significant increase in cancer cases from a pandemic that has already killed more than a quarter of a million people worldwide, as well as in people returning from overseas who may have not been previously diagnosed.
The U.K. Surgeons’ Council announced Friday that the first of a series of five new trials of the first-ever drug approved for the treatment of invasive colorectal cancer is set to begin in the U.k. and the U, and that a second trial will be opened in April.
The news was announced just hours after the World Health Organization announced that more than half of all cancer cases in the United States will now be detected and treated by next year.
More than 3,000 people died in the pandemic.
The U, however, has been slow to adopt the drug.
The country’s top surgeon, Sir Simon Chapman, has said the country needs to develop a better vaccine and that the government is unlikely to approve the drug until the end of the year.